News ArticlesNext Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian CancerOvarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early detection and there is an urgent need to identify novel biomarkers...Read more Upcoming EventsNext-Generation Protein Analysis and DetectionMay 30, 2022 - May 31, 2022Cecilia Lindskog will present "The Human Protein Atlas - spatial proteomics for single cell analysis"Jochen Schwenk will talk on the subject "Precision phenotyping with the circulating proteome" FEBS Practical and Lecture CourseSeptember 11, 2022 - September 16, 2022FEBS Practical and Lecture Course - A summer school aimed at graduate students, post-docs, and young independent investigators who want to learn about new techniques to explore the proteins encoded by the human genome. News article |